NEW YORK – DNA technology startup Genetics Research said on Tuesday that Oxford Nanopore Technologies has licensed its intellectual property relating to CRISPR-based DNA target enrichment.
Under the non-exclusive agreement, Oxford Nanopore can include the technology, which targets long DNA fragments with specific sequences, in its DNA and RNA nanopore sequencing products.
Financial and other terms of the deal were not disclosed.
Genetics Research, based in Wakefield, Massachusetts, has developed a low-cost sequence-specific technology platform, called Negative Enrichment, that uses CRISPR/Cas9 to enrich DNA fragments from a complex background.